Farallon Capital Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Farallon Capital Management’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-15,870	Closed	-$2.37M	–	81
2015 Q3	$2.37M	Sell	15,870 -1,530	-9%	-$1.12M	0.03%	76
2015 Q2	$16.5M	Buy	17,400 +4,250	+32%	+$3.47M	0.22%	58
2015 Q1	$9.64M	Buy	+13,150	New	+$9.88M	0.14%	70
2013 Q3	–	Sell	-5,547	Closed	-$780K	–	87
2013 Q2	$780K	Buy	+5,547	New	+$878K	0.02%	81

Other funds holding TTPH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Farallon Capital Management's TTPH Position: Q4 2015 in Review

Farallon Capital Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2015, closing a stake of 15,870 shares — an estimated $2.37M sold.

Farallon Capital Management first reported a position in TTPH in Q2 2013 and held it in 4 quarters. The position peaked at $16.5M in Q2 2015. 105 funds tracked by Wall St. Rank hold TTPH as of Q4 2015.

Farallon Capital Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
Farallon Capital Management sold 15,870 Tetraphase Pharmaceuticals, Inc. shares in Q4 2015, an estimated $2.37M.
Farallon Capital Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 4 quarters.
Farallon Capital Management's Tetraphase Pharmaceuticals, Inc. position peaked at $16.5M in Q2 2015.
105 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2015.

Based on Farallon Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.